In experimental models, the overexpression of GPR65 in cancer cell lines (such as Lewis lung carcinoma) protected tumour cells from acidosis-induced death and stimulated in vivo tumour growth, while knockout or deficiency of GPR65 has been linked to diminished tumour progression in both solid and haematological cancers [59,60,66]. Here, GPR65 is linked to neoplasm.